Vistakon Investigational Multi-Purpose Solution I
DeviceMulti-purpose contact lens care solution.
NCT Number: NCT01055613
This study compares an investigational contact lens care multi-purpose solution to a currently marketed multi-purpose solution.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Fresno, California, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Multi-purpose contact lens care solution.
Multi-purpose contact lens care solution
Time frame: 3 months
Each subjects' eye was examined using a bio-microscope. Slit lamp findings were graded with a 5-point scale (i.e. Grade 0= None, Grade 1 = trace, Grade 2 = Mild, Grade 3 = moderate and Grade 4 = severe). The number of eyes with Grade 3 or higher for each lens was reported for each assessment.
Time frame: Up to 3 Months
Distance visual acuity was collected at the 1-, 2-, 3-week and 1- and 3- month follow-up evaluations. The average LogMAR across all visits for each lens type was reported.
Johnson & Johnson Vision Care, Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04175340
Contact Lens Wear
San Francisco, California, United States
View Trial DetailsNCT03897751
Contact Lens Wear
Birmingham, Alabama, United States
View Trial DetailsNCT03897712
Contact Lens Wear
San Francisco, California, United States
View Trial DetailsNCT02701556
Contact Lens Wear
Pittsburg, Kansas, United States
View Trial Details